Cargando…

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis

There is increasing interest in the development of multiple sclerosis (MS) biomarkers that reflect central nervous system tissue injury to determine prognosis. We aimed to assess the prognostic value of kinesin superfamily motor protein KIF5A in MS by measuring levels of KIF5A in cerebrospinal fluid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hares, Kelly, Kemp, K., Loveless, S., Rice, C. M., Scolding, N., Tallantyre, E., Robertson, N., Wilkins, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179895/ https://www.ncbi.nlm.nih.gov/pubmed/33484325 http://dx.doi.org/10.1007/s00415-020-10373-w

Ejemplares similares

Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum
por: Redondo, Juliana, et al.
Publicado: (2014)

Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection
por: Sarkar, Pamela, et al.
Publicado: (2021)

Reductions in kinesin expression are associated with nitric oxide-induced axonal damage
por: Redondo, Juliana, et al.
Publicado: (2015)

Mesenchymal Stem Cells Restore Frataxin Expression and Increase Hydrogen Peroxide Scavenging Enzymes in Friedreich Ataxia Fibroblasts
por: Kemp, Kevin, et al.
Publicado: (2011)

Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment
por: Witherick, Jonathan, et al.
Publicado: (2010)

Dysregulation of Mesenchymal Stromal Cell Antioxidant Responses in Progressive Multiple Sclerosis
por: Redondo, Juliana, et al.
Publicado: (2018)

Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis
por: Sarkar, Pamela, et al.
Publicado: (2018)

Continuous evolution of magnetic resonance imaging in multiple sclerosis
por: Tallantyre, E. C., et al.
Publicado: (2016)

An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia
por: Kemp, Kevin C., et al.
Publicado: (2022)

Early MRI predictors of prognosis in multiple sclerosis
por: Davda, Nikunj, et al.
Publicado: (2019)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

How to run a multiple sclerosis relapse clinic
por: Tallantyre, Emma C, et al.
Publicado: (2016)

Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice
por: Kemp, Kevin C., et al.
Publicado: (2018)

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis
por: Welton, Joanne L., et al.
Publicado: (2017)

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro
por: Redondo, Juliana, et al.
Publicado: (2017)

Cell fusion in the brain: two cells forward, one cell back
por: Kemp, Kevin, et al.
Publicado: (2014)

Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model
por: Kemp, Kevin C., et al.
Publicado: (2017)

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
por: Beesley, R., et al.
Publicado: (2022)

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)
por: Rice, Claire M, et al.
Publicado: (2015)

Systemic complement profiling in multiple sclerosis as a biomarker of disease state
por: Ingram, G, et al.
Publicado: (2012)

KIF3A and IL-4 are disease-specific biomarkers for psoriatic arthritis susceptibility
por: Cascella, Raffaella, et al.
Publicado: (2017)

Tract-specific MRI measures explain learning and recall differences in multiple sclerosis
por: Winter, Mia, et al.
Publicado: (2021)

Cell-based therapeutic strategies for multiple sclerosis
por: Scolding, Neil J, et al.
Publicado: (2017)

An observational study of alemtuzumab following fingolimod for multiple sclerosis
por: Willis, Mark, et al.
Publicado: (2017)

Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level
por: Barac, Ioana S., et al.
Publicado: (2021)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
por: Gray, Elizabeth, et al.
Publicado: (2012)

Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells
por: Kemp, Kevin, et al.
Publicado: (2017)

Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci
por: McCauley, Jacob L., et al.
Publicado: (2010)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

Tractography in the presence of multiple sclerosis lesions
por: Lipp, Ilona, et al.
Publicado: (2020)

Update on the Phenotypic and Genotypic Spectrum of KIF11-Related Retinopathy
por: Wang, You, et al.
Publicado: (2022)

Hepatotoxicity of Drugs Used in Multiple Sclerosis, Diagnostic Challenge, and the Role of HLA Genotype Susceptibility
por: Meunier, Lucy, et al.
Publicado: (2023)

Neurosarcoidosis: a clinical approach to diagnosis and management
por: Ibitoye, Richard T., et al.
Publicado: (2016)

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

Smoking and multiple sclerosis susceptibility
por: Hedström, Anna Karin, et al.
Publicado: (2013)

Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis
por: Lipp, Ilona, et al.
Publicado: (2019)

Association of variants in the KIF1A gene with amyotrophic lateral sclerosis
por: Liao, Panlin, et al.
Publicado: (2022)

Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells
por: Kemp, K, et al.
Publicado: (2011)

Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population
por: Clarelli, Ferdinando, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3iuur0kbfuomktq21g2g8bli6d